Cargando…
Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance
BACKGROUND: Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992070/ https://www.ncbi.nlm.nih.gov/pubmed/21054863 http://dx.doi.org/10.1186/1475-2875-9-312 |
_version_ | 1782192703159664640 |
---|---|
author | Beshir, Khalid B Hallett, Rachel L Eziefula, Alice C Bailey, Robin Watson, Julie Wright, Stephen G Chiodini, Peter L Polley, Spencer D Sutherland, Colin J |
author_facet | Beshir, Khalid B Hallett, Rachel L Eziefula, Alice C Bailey, Robin Watson, Julie Wright, Stephen G Chiodini, Peter L Polley, Spencer D Sutherland, Colin J |
author_sort | Beshir, Khalid B |
collection | PubMed |
description | BACKGROUND: Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some patients exhibit an extended parasite clearance time in the three days immediately following treatment with artesunate monotherapy. This phenotype is likely to become a more important trial endpoint in studies of anti-malarial drug efficacy, but currently requires frequent, closely spaced blood sampling in hospitalized study participants, followed by quantitation of parasite density by microscopy. METHODS: A simple duplex quantitative PCR method was developed in which distinct fluorescent signals are generated from the human and parasite DNA components in each blood sample. The human amplification target in this assay is the β tubulin gene, and the parasite target is the unique methionine tRNA gene (pgmet), which exhibits perfect sequence identity in all six Plasmodium species that naturally infect humans. In a small series of malaria cases treated as hospital in-patients, the abundance of pgmet DNA was estimated relative to the human DNA target in daily peripheral blood samples, and parasite clearance times calculated. RESULTS: The qPCR assay was reproducibly able to replicate parasite density estimates derived from microscopy, but provided additional data by quantification of parasite density 24 hours after the last positive blood film. Robust estimates of parasite clearance times were produced for a series of patients with clinical malaria. CONCLUSIONS: Large studies, particularly in Africa where children represent a major proportion of treated cases, will require a simpler blood sample collection regime, and a method capable of high throughput. The duplex qPCR method tested may fulfil these criteria, and should now be evaluated in such field studies. |
format | Text |
id | pubmed-2992070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29920702010-12-20 Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance Beshir, Khalid B Hallett, Rachel L Eziefula, Alice C Bailey, Robin Watson, Julie Wright, Stephen G Chiodini, Peter L Polley, Spencer D Sutherland, Colin J Malar J Research BACKGROUND: Artemisinin-based combination therapy, currently considered the therapy of choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under threat from newly emerging parasite resistance to the artemisinin family of drugs. Studies in Southeast Asia suggest some patients exhibit an extended parasite clearance time in the three days immediately following treatment with artesunate monotherapy. This phenotype is likely to become a more important trial endpoint in studies of anti-malarial drug efficacy, but currently requires frequent, closely spaced blood sampling in hospitalized study participants, followed by quantitation of parasite density by microscopy. METHODS: A simple duplex quantitative PCR method was developed in which distinct fluorescent signals are generated from the human and parasite DNA components in each blood sample. The human amplification target in this assay is the β tubulin gene, and the parasite target is the unique methionine tRNA gene (pgmet), which exhibits perfect sequence identity in all six Plasmodium species that naturally infect humans. In a small series of malaria cases treated as hospital in-patients, the abundance of pgmet DNA was estimated relative to the human DNA target in daily peripheral blood samples, and parasite clearance times calculated. RESULTS: The qPCR assay was reproducibly able to replicate parasite density estimates derived from microscopy, but provided additional data by quantification of parasite density 24 hours after the last positive blood film. Robust estimates of parasite clearance times were produced for a series of patients with clinical malaria. CONCLUSIONS: Large studies, particularly in Africa where children represent a major proportion of treated cases, will require a simpler blood sample collection regime, and a method capable of high throughput. The duplex qPCR method tested may fulfil these criteria, and should now be evaluated in such field studies. BioMed Central 2010-11-05 /pmc/articles/PMC2992070/ /pubmed/21054863 http://dx.doi.org/10.1186/1475-2875-9-312 Text en Copyright ©2010 Beshir et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Beshir, Khalid B Hallett, Rachel L Eziefula, Alice C Bailey, Robin Watson, Julie Wright, Stephen G Chiodini, Peter L Polley, Spencer D Sutherland, Colin J Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
title | Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
title_full | Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
title_fullStr | Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
title_full_unstemmed | Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
title_short | Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance |
title_sort | measuring the efficacy of anti-malarial drugs in vivo: quantitative pcr measurement of parasite clearance |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992070/ https://www.ncbi.nlm.nih.gov/pubmed/21054863 http://dx.doi.org/10.1186/1475-2875-9-312 |
work_keys_str_mv | AT beshirkhalidb measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT hallettrachell measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT eziefulaalicec measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT baileyrobin measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT watsonjulie measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT wrightstepheng measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT chiodinipeterl measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT polleyspencerd measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance AT sutherlandcolinj measuringtheefficacyofantimalarialdrugsinvivoquantitativepcrmeasurementofparasiteclearance |